Geraldine Hamilton, PhD, is the president and chief scientific officer of Emulate, Inc. Prior to joining Emulate's founding team, she served as lead senior staff scientist at the Wyss Institute for Biologically Inspired Engineering at Harvard University. At the Wyss Institute, Hamilton led the Organs-on-Chips program and managed the multidisciplinary team responsible for developing, translating and commercializing the Organs-on-Chips technology. Hamilton's career spans industry, academia and the start-up world. Prior to her tenure at Harvard University, Hamilton spent more than 11 years in the pharmaceutical industry in leadership roles managing drug discovery teams. Her research achievements helped advance the development and application of human-relevant in vitro models for drug discovery. Hamilton received her PhD in cell biology/toxicology from the University of Hertfordshire in England in conjunction with GlaxoSmithKline, followed by a post-doctoral research fellowship at the University of North Carolina. She has authored more than 40 publications and has numerous patents.